Arthos J, Deen K C, Shatzman A, Truneh A, Rosenberg M, Sweet R W
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19479.
Ann N Y Acad Sci. 1990;616:116-24. doi: 10.1111/j.1749-6632.1990.tb17833.x.
Through mutagenesis, we identified a single high-affinity binding site for gp120 on the human CD4 protein. This site is localized in the V1 domain within residues 41 to 55. The collection of mutants was also used to define the epitopes for 55 anti-CD4 monoclonal antibodies. The locations of these epitopes are consistent with a V kappa-like structure for the V1 domain. In the context of this structure, the gp120 binding site encompasses the small CDR2 loop. Through deletion mutagenesis at the termini of the V1 domain, we further defined the minimal region required to retain high-affinity binding to gp120. Short deletions at both termini disrupt binding to gp120 and recognition by conformation-sensitive anti-CD4 monoclonal antibodies. We conclude that amino acids at both the amino and carboxy termini are critical to the conformation of the V1 domain and, in particular, to the integrity of the gp120 binding site.
通过诱变,我们在人CD4蛋白上鉴定出一个gp120的单一高亲和力结合位点。该位点位于41至55位残基的V1结构域内。突变体集合还用于确定55种抗CD4单克隆抗体的表位。这些表位的位置与V1结构域的Vκ样结构一致。在这种结构背景下,gp120结合位点包含小的互补决定区2(CDR2)环。通过在V1结构域末端进行缺失诱变,我们进一步确定了与gp120保持高亲和力结合所需的最小区域。两端的短缺失会破坏与gp120的结合以及构象敏感抗CD4单克隆抗体的识别。我们得出结论,氨基末端和羧基末端的氨基酸对V1结构域的构象至关重要,特别是对gp120结合位点的完整性至关重要。